Drug
Ak129 Infusion
Ak129 Infusion: highest development phase Phase 1, developed by Akeso. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Akeso
Trials
| Drug | Phase | Indication |
|---|---|---|
| AK129 IV infusion NCT05645276 | Phase 1 | Advanced Malignant Tumors(Stage IA-IB) |
Latest
No recent events.
Follow Ak129 Infusion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.